Table 1. Clinical and laboratory findings in five patients with Guillain-Barré syndrome from whom Campylobacter jejuni was isolated and used in the current studya.
| Patients | BD-39 | BD-07 | BD-10 | BD-67 | BD-94 |
| Clinical characteristics | |||||
| Age (years) | 30 | 40 | 15 | 40 | 10 |
| Sex | F | M | M | M | F |
| Diarrhoea | + | + | + | + | – |
| Days to nadir | 12 | 2 | 5 | 6 | 3 |
| Ophthalmoplegia | – | – | + | + | – |
| Sensory deficits | – | – | – | – | – |
| Motor deficits | + | + | + | + | + |
| GBS disability score | |||||
| At nadir | 5 | 4 | 5 | 4 | 5 |
| At 26 weeks | 4 | 0 | 3 | 3 | 4 |
| Serology | |||||
| Anti-GM1 IgG | + | – | – | + | – |
| Anti-GD1a IgG | – | + | + | + | – |
| Anti-GQ1b IgG | – | – | + | + | – |
| C. jejuni serology | + | + | + | + | + |
| C. jejuni isolates | |||||
| Penner serotype | HS:19 | HS:19 | HS:23 | HS:23 | HS:21 |
a. Abbreviations: M, Male; F, Female; +, present; -, absent; N, normal, GBS disability score (6).